Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
Kamran MA Aziz Aseer Diabetes Center, Aseer Central Hospital, Ministry of Health, Abha, Saudi Arabia Abstract: Diabetes management during Ramadan fasting is challenging to the physician in terms of minimizing the risk of hypoglycemia. As compared to oral hypoglycemic agents (OHAs) and sulfonylureas...
Enregistré dans:
Auteur principal: | Aziz KMA |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ce42027a5dff45f9a689e17a89fda098 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
par: AlMaatouq MA
Publié: (2012) -
Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
par: Al Sifri S
Publié: (2012) -
Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
par: Hassoun AAK, et autres
Publié: (2016) -
Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
par: Nishio S, et autres
Publié: (2015) -
Self-Monitoring of Blood Glucose and Hypoglycemia Association During Fasting in Ramadan Among Patients with Diabetes
par: Mansouri D, et autres
Publié: (2020)